Table 3.

Concentration range of urinary LAM measured using MoAb1, CS35 and A194 mAbs, ng/mL (IQR).

Median LAM concentration, ng/mL (IQR)
	Tot #	MoAb1	CS35	A194	Combination
TB positive	219	0.5 (1.50)	0.46 (1.52)	0.20 (0.32)	0.48 (1.08)
Adults	200	0.51 (1.60)	0.48 (1.57)	0.19 (0.31)	0.52 (1.10)
Pediatric	19	0.46 (0.91)	0.23 (0.62)	0.07 (0.41)	0.14 (0.24)
PTB	195	0.46 (0.54)	0.45 (1.54)	0.20 (0.31)	0.45 (1.00)
EPTP	24	1.40 (1.83)	0.84 (1.24)	0.194 (0.25)	0.73 (1.47)
HIV status
Positive	55	0.46 (1.62)	1.19 (3.21)	0.30 (0.36)	0.79 (1.45)
Negative	164	0.52 (1.56)	0.55 (1.21)	0.13 (0.14)	0.40 (0.83)
Glycosuria
Positive	24	0.76 (1.78)	0.21 (0.43)	0.11 (0.26)	0.44 (0.68)
Negative	195	0.49 (1.55)	0.56 (1.61)	0.20 (0.31)	0.47 (1.09)
Countries
Peru	80	0.35 (1.19)	0.23 (0.89)	0.13 (0.22)	0.35 (0.66)
Guinea Bissau	17	0.54 (1.63)	0.004 (0.23)	0.031 (0.06)	0.31 (0.62)
Uganda	97	0.46 (1.30)	0.83 (2.22)	0.28 (0.37)	0.66 (1.39)
Venezuela	25	1.59 (1.78)	0.93 (1.17)	0.24 (0.40)	0.87 (1.46)

PTB pulmonary tuberculosis, EPTB extrapulmonary tuberculosis.